Filing Details
- Accession Number:
- 0001209191-20-020959
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-24 16:58:10
- Reporting Period:
- 2020-03-20
- Accepted Time:
- 2020-03-24 16:58:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1649904 | Rhythm Pharmaceuticals Inc. | RYTM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1473930 | Todd Foley | C/O Mpm Asset Management 450 Kendall Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-03-20 | 1,100 | $15.00 | 2,361,763 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Shares were sold as follows: 1,058 by BV V and 42 by AM BV5.
- The price in Column 4 is a weighted average sale price. The prices actually received ranged from $15.00 to $15.01. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Shares are held as follows: 2,273,457 by BV V and 88,306 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.